Endometriosis is one of the most stubborn conditions in women’s health. Around one in ten women of reproductive age live with it, and for many it means years of pain, heavy periods, fatigue, and sometimes infertility. Current treatments aren’t ideal. Hormone suppression often brings unpleasant side effects, and surgery carries risks of recurrence — up to 40% of women need repeat operations within five years.
Vesicle-Based Corridor Therapies for Endometriosis
I’ve just published a new paper that proposes a different way forward: vesicle-based corridor therapies. This sounds technical, so let’s unpack it.
What makes endometriosis so hard to treat?
Endometrial tissue belongs in the uterus, where it follows a precise monthly cycle. But in endometriosis, those same cells appear outside — on ovaries, bowel, bladder, or peritoneum. Instead of behaving, they build tiny “corridors” that don’t match the tissue around them. Think of it as electrical wiring crossed at the wrong angle. The result is constant irritation: inflammation, blood vessel growth, and nerve invasion that produces chronic pain.
Worse still, these mis-corridors can “train” the surrounding proteins to fold in ways that lock the wiring in place. That’s why the disease often comes back even after surgeons cut away visible lesions. The anchors remain.
How could vesicles help?
Vesicles are tiny biological bubbles, and they can be programmed to recognise these corridor mismatches. There are two main strategies:
-
Intrinsic recognition — vesicles are tuned to the unique signature of misplaced endometrial tissue. They bind only to the ectopic lesions and trigger those cells to self-destruct, while leaving healthy uterine tissue untouched.
-
Clinician-guided highlighting — vesicles stay quiet until a doctor “paints” the lesion with a safe external signal (such as focused ultrasound or a light probe). Only then do they activate and remove the marked tissue.
It’s a bit like how a military laser designator works in video games: the operator marks the target, and the smart system delivers the strike — but here it’s all done organically and with safety locks.
Why this is different
-
No hormones: avoids side effects like bone thinning or mood changes.
-
No excision scars: tissue is cleared biologically, not cut.
-
Less recurrence: because vesicles can collapse the underlying corridor anchors, not just trim surface tissue.
-
Flexible toolbox: the same method could extend to fibroids, adhesions, or even some early cancers.
Safety first
This technology also comes with strict safeguards. Vesicles would need two or more “yes” signals before acting (wrong tissue + external highlight). Devices would be locked to licensed clinicians. And vesicles would be short-lived, clearing safely if unused.
Looking ahead
It’s still early days. The work is at a conceptual and preclinical stage. But the idea shifts endometriosis treatment away from “cutting out” and towards retraining biology itself to dissolve misplaced tissue.
For women living with endometriosis, the hope is clear: a future with fewer surgeries, fewer side effects, and more targeted relief.
You can read the full scientific paper here:
Vesicle-Based Corridor Therapies for Endometriosis
Comments
Post a Comment